The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice.
Saved in:
| Title: | The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese Mice. |
|---|---|
| Authors: | Oliveira AL; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil., Medeiros ML; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil., Campos ATP; Department of Physics of Federal Ceara, University of Ceara (UFC), Fortaleza 60440-900, CE, Brazil., Cesar CL; Department of Physics of Federal Ceara, University of Ceara (UFC), Fortaleza 60440-900, CE, Brazil., Mónica FZ; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil., Antunes E; Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13084-971, SP, Brazil. |
| Source: | Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2025 Jun 27; Vol. 14 (7). Date of Electronic Publication: 2025 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
